EyeControl is an innovative startup in the healthcare industry, providing a groundbreaking ICU communication platform for ventilated patients, medical teams, and families. The company leverages disruptive AI-technologies to bridge information barriers and enable better medical care and decision-making. Through their eye-tracking wearable and smart platforms, EyeControl empowers communication for non-verbal patients, their families, and medical teams, thereby revolutionizing medical communication standards. EyeControl offers two main products: EyeControl-Med, a communication solution for healthcare facilities that facilitates bi-directional remote connectivity, and EyeControl-Home, a comprehensive communication solution for patients transitioning from medical facilities to remote home care. Both solutions aim to improve clinical outcomes and enhance the quality of life for non-verbal patients. Founded in 2016 and headquartered in Israel, EyeControl recently secured a significant €841.75K Venture Round investment from The European Innovation Council on 15 September 2023. With its focus on addressing unmet healthcare needs and implementing cutting-edge technologies, EyeControl has the potential to make a substantial impact in the healthcare industry, particularly in improving communication and care for non-verbal patients.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | €841.75K | 1 | 15 Sep 2023 | |
Grant | Unknown | 1 | 19 Jan 2023 | |
Series A | $7.50M | 10 | Jim Elkind, Itsik Danziger +2 | 12 Aug 2020 |
Grant | $2.50M | 1 | 12 Aug 2020 | |
Grant | $750.00K | 1 | VentureClash | 28 Oct 2019 |
No recent news or press coverage available for EyeControl.